N-(2H-1,3-benzodioxol-5-yl)propanamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: N-(2H-1,3-benzodioxol-5-yl)propanamide
• 英文别名: N-(1,3-benzodioxol-5-yl)propanamide
• 化学式: C₁₀H₁₁NO₃
• mdl: MFCD01342450
• 分子量: 193.2
• InChiKey: YYZAIRCRSGDQPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Substituted hydroxamic acids and uses thereof
  申请人：Blackburn Christopher

  公开号：US20110039827A1

  公开（公告）日：2011-02-17

  This invention provides compounds of formula (I): wherein R 1 , R 2 , G, m, n, p and q have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.

  本发明提供了式(I)的化合物：其中R1、R2、G、m、n、p和q的值如规范中所述，可用作HDAC6抑制剂。本发明还提供了包含本发明化合物的药物组合物以及使用这些组合物治疗增生性、炎症性、感染性、神经系统或心血管疾病或障碍的方法。
• INHIBITORS OF LATE SV40 FACTOR (LSF) AS CANCER CHEMOTHERAPEUTICS
  申请人：TRUSTEES OF BOSTON UNIVERSITY

  公开号：US20170107227A1

  公开（公告）日：2017-04-20

  The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III′) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
• US7244847B2
  申请人：——

  公开号：US7244847B2

  公开（公告）日：2007-07-17
• [EN] INHIBITORS OF HIV REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIH
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2011143772A1

  公开（公告）日：2011-11-24

  Compounds of formula (I) wherein R1, R2, n and R3 are defined herein, are useful as inhibitors of HIV replication.